INSP INSP
Company Profile ↓Company Overview
INSP (INSP) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 18.6%, reflecting efficient use of shareholder capital.
Revenue has grown at a 56.2% CAGR over the past five years.
Trades at an undemanding P/E of 12.3.
Maintains a net profit margin of 16.0%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $911.98M (+13.6% YoY); net profit $145.42M.
- Trailing 12 Months Year-on-year growth — revenue +13.6%, earnings +171.8%.
- 5-Year Trend Long-term compounding — revenue CAGR 56.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 56.25% |
| 1 Year: | 13.60% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | 171.77% |
Stock Price Performance
| 1 Year: | -53.76% |
| 6 Months: | -16.66% |
| 3 Months: | +24.54% |
| 1 Month: | +19.99% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)66.27 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 56.2% over 5 years.
- Generates positive free cash flow.
CONS
- Trading 58.3% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 10.04M | 10.94M | 13.05M | - | 16.25M | 18.03M | 20.86M | 26.91M | 21.35M | 12.18M | 35.84M | 46.01M | 40.35M | 52.96M | 61.69M | 69.38M | 91.39M | 109.19M | 127.90M | 151.09M | 153.30M | 164.01M | 195.88M | 203.19M | 201.32M | 217.09M | 224.50M | 204.58M | 200.58M |
| Gross Profit | 4.10M | 4.67M | 5.71M | 8.08M | 7.75M | 8.84M | 10.59M | 13.37M | 13.40M | 14.94M | 17.41M | 22.67M | 18.05M | 10.23M | 30.63M | 38.85M | 34.37M | 45.44M | 53.06M | 59.38M | 77.21M | 89.40M | 108.01M | 126.84M | 128.92M | 139.25M | 166.04M | 170.79M | 170.61M | 182.41M | 192.73M | 176.91M | 171.46M |
| Operating Income | -4.12M | -4.38M | -3.65M | - | -5.20M | -5.64M | -4.65M | - | -8.78M | -8.18M | -8.65M | - | -16.44M | -22.81M | -9.89M | - | -15.69M | -12.54M | -9.80M | -16.06M | -14.01M | -17.19M | -19.50M | -16.60M | -13.47M | -15.22M | 5.10M | 14.32M | -1.49M | -3.32M | 9.64M | -1.12M | -514.00K |
| Net Income | -4.48M | -4.76M | -4.02M | -4.25M | -6.50M | -5.86M | -4.69M | -4.78M | -8.27M | -7.65M | -8.25M | -9.08M | -16.25M | -23.09M | -10.38M | -7.48M | -16.22M | -13.09M | -10.35M | -16.69M | -14.49M | -16.85M | -15.42M | -11.95M | -8.54M | -10.01M | 9.79M | 18.50M | 2.99M | -3.59M | 9.93M | -11.29M | 314.00K |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.88 | -0.39 | - | -0.60 | -0.48 | -0.38 | -0.61 | -0.53 | -0.60 | -0.53 | -0.41 | -0.29 | -0.34 | 0.32 | 0.60 | 0.10 | -0.12 | 0.34 | -0.39 | 0.01 |
| R&D Expense | 1.59M | 1.74M | 1.18M | - | 1.73M | 1.74M | 1.77M | - | 2.60M | 2.85M | 3.62M | - | 5.44M | 6.06M | 7.31M | - | 8.15M | 9.29M | 9.61M | 11.87M | 14.53M | 20.99M | 25.52M | 30.82M | 29.14M | 28.85M | 28.86M | 26.08M | 27.80M | 26.21M | 24.21M | 25.83M | 24.70M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16.43M | 28.57M | 50.59M | 82.05M | 115.38M | 233.39M | 407.86M | 624.80M | 802.80M | 911.98M |
| Gross Profit | 12.52M | 22.55M | 40.54M | 68.41M | 97.76M | 200.12M | 341.74M | 528.22M | 679.82M | 778.76M |
| Operating Income | -17.25M | -16.00M | -20.38M | -34.90M | -56.21M | -39.85M | -47.59M | -40.27M | 36.08M | 50.95M |
| Net Income | -18.53M | -17.51M | -21.83M | -33.24M | -57.20M | -42.04M | -44.88M | -21.15M | 53.51M | 145.42M |
| Diluted EPS | - | - | - | -1.40 | -2.19 | -1.54 | -1.60 | -0.72 | 1.75 | 4.89 |
| R&D Expense | 7.09M | 6.19M | 7.39M | 12.84M | 26.09M | 37.35M | 68.64M | 116.54M | 114.13M | 103.17M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Jan 2019 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 25.09M | 200.08M | 200.09M | 181.25M | 281.19M | 295.08M | 564.88M | 676.81M | 808.38M | 907.32M |
| Total Equity | -1.14M | -6.61M | 1.33M | 164.00M | - | 139.84M | 229.75M | 229.05M | 496.01M | 572.51M | 689.70M | 781.16M |
| Cash & Equivalents | 12.13M | 6.68M | 8.96M | 97.29M | - | 22.86M | 190.52M | 214.47M | 441.59M | 185.54M | 150.15M | 104.81M |
| Long Term Debt | - | - | - | 24.50M | - | 24.50M | 24.50M | 24.50M | - | - | - | - |
| Total Liabilities | - | - | 23.76M | 36.08M | 36.09M | 41.42M | 51.44M | 66.04M | 68.87M | 104.30M | 118.69M | 126.16M |
| Current Liabilities | - | - | 7.15M | 11.15M | 11.17M | 16.86M | 20.73M | 41.31M | 61.19M | 78.11M | 88.50M | 96.06M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -17.95M | -15.79M | -18.69M | -32.85M | -53.05M | -20.12M | 11.57M | 24.65M | 130.25M | 116.98M |
| Investing Cash Flow | -306.00K | -7.60M | -83.39M | -43.56M | 86.63M | 29.14M | -19.60M | -294.82M | -113.12M | 21.45M |
| Financing Cash Flow | 12.81M | 25.66M | 190.38M | 1.96M | 134.06M | 14.95M | 235.08M | 13.95M | -52.39M | -183.45M |
| Capital Expenditure | -306.00K | -412.00K | -250.00K | -2.74M | -2.46M | -4.67M | -9.10M | -23.63M | -39.12M | -38.50M |
| Free Cash Flow | -18.25M | -16.20M | -18.94M | -35.59M | -55.50M | -24.79M | 2.47M | 1.02M | 91.12M | 78.48M |
| Share Buybacks | - | - | - | - | - | - | 0 | 0 | 0 | 175.02M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 76.2% | 78.9% | 80.1% | 83.4% | 84.7% | 85.7% | 83.8% | 84.5% | 84.7% | 85.4% |
| Operating Margin % | -105.0% | -56.0% | -40.3% | -42.5% | -48.7% | -17.1% | -11.7% | -6.4% | 4.5% | 5.6% |
| Net Margin % | -112.8% | -61.3% | -43.1% | -40.5% | -49.6% | -18.0% | -11.0% | -3.4% | 6.7% | 15.9% |
| ROE % | 280.4% | -1,319.6% | -13.3% | -23.8% | -24.9% | -18.4% | -9.0% | -3.7% | 7.8% | 18.6% |
| ROCE % | - | -89.2% | -10.8% | -21.2% | -21.6% | -15.7% | -9.4% | -6.7% | 5.0% | 6.3% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for INSP
INSP's 28.1% Past-Month Rally Raises a Key Question for Investors - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxNaEo2bXB6M0E4LXNNN3lIRngxLV9OdjR3Sk1EWWdLRXR5WlA4TElfdzI0dVdxeEdMMjJDS2M3VERYNGNkblBCVTBIcGJ5dHNwZnBNcnJRNFowVkp2ZTBPVlpBaDdIRUVJVUd2UVJHMEtMUjZySEpuNkVMRUQ5dW80dE5lYjluOXhadUxxcn…
Inspire Medical Systems (INSP) Stock Jumps As Profit Returns Through Revenue Slip - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxNRlpnZnRWY1FOQmFDaWdTWTV5b3E0TGpuUnhCa3o0NnF4bFBuZ1dseVZMeFFXNmw4WDc3cG9ueHphdXlzVkVIQ1M2eGlENVVEeFdTM0p4blQ1Rkd4Wlc5UC0tdnA1LV9NOG9EemxXcTJNZTRKZkdCUnBjX2U4TWY1Z1VoYks2RloyLVM1cF…
$INSP stock is up 21% today. Here's what we see in our data. - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxNNXdVdEdxSHBWU3JxTDc4UEhlekZXc2tuZTJuMXdqOEdOb0tXekxrRFJFdW93OTV3Mkx1elRXREhUU0oyRldPeTVtNENZY2Jocmh5X0xESlNCdXJLN09nVkNmN0Ftb09iVFpyODVJSndPYnpacUhQb3FoQXZ2eEJlRDVlVkhnTG4xU2NwVG…
INSP Raises 2026 Outlook as Reimbursement Headwinds Start to Ease - TradingView
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxPMkp2SWkyQzQ3MG9JTlEzSHpFaElzNTdwMjJqT2hPc0l0QXhtWFFIX3RvVkRsS2xvcldMbzRnbkdfeUozMktwWktwNFgyTHRhODdFQUZQdlhnNy1kMTBOWE5HdWlsZG1PQUtwN1M3Q0Q3YUxBNjJ1LVRTZ2tqdGVoM05zYkVPV2Voc0g1TU…
Is INSP a Buy as Margins Improve but Reimbursement Risks Persist? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxNWGo2UW54R2FlWTlwMHNTemROdldBREJRUms3S1UtVFlVSFBGN3R5N2otOHJnU3NwWHZVYWFyS05aNF9ZZ2V5V2tqNjZrLV9sN3kzVlIzN0kwdFRYSnROQmU5ekRUWHkyU0c4dzFic3B0aWo3azhFNGIwNklXR0I4Mjdfbl9VellkNzlhcH…
Inspire Medical Systems (NYSE: INSP) files Form 4 on RSU tax withholding - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxNWk5tWkhRaUp3TFJ6NUNJN2MzYnplZXZQYWpDMG03UlR3cGJRbjd4THlPeTR6Y3d2SmdfbExVSWZfTFZ5ZnZWajhxTUFWVWVzSlBiblR6WjFaWnp1UjhUbzJGUDBwME9mNXE4TzhORVBGTW1vem9OcVE4X1M2NXdwQ09XWVc0TXdjd2lYbH…
INSP — Frequently Asked Questions
What is the current share price of INSP?
As of 2026-08-05 17:25 PDT, INSP trades at $60.09 on NASDAQ/NYSE. Its 52-week range is $40.05 to $143.99.
What is the P/E ratio of INSP?
INSP trades at a trailing price-to-earnings (P/E) ratio of 12.29.
What is the return on equity (ROE) of INSP?
INSP has a return on equity (ROE) of 18.62%. Its return on capital employed (ROCE) is 6.28%.
Is INSP a good stock to buy?
This page provides a data-driven analysis of INSP, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.